{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:09:08Z","timestamp":1792166948519,"version":"4.4.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"MEXT","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"MHLW","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.nmd.2015.05.002","type":"journal-article","created":{"date-parts":[[2015,5,8]],"date-time":"2015-05-08T12:02:21Z","timestamp":1431086541000},"page":"667-671","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["A missense mutation in domain III in HSPG2 in Schwartz\u2013Jampel syndrome compromises secretion of perlecan into the extracellular space"],"prefix":"10.1016","volume":"25","author":[{"given":"Satoshi","family":"Iwata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikako","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Nakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichiro","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Okuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bisei","family":"Ohkawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohide","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Osaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Nonaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Arikawa-Hirasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinji","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2015.05.002_bib0010","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/archopht.1962.00960030056011","article-title":"Congenital blepharophimosis associated with a unique generalized myopathy","volume":"68","author":"Schwartz","year":"1962","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.nmd.2015.05.002_bib0015","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/82638","article-title":"Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia)","volume":"26","author":"Nicole","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.nmd.2015.05.002_bib0020","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1086\/340390","article-title":"Structural and functional mutations of the perlecan gene cause Schwartz-Jampel syndrome, with myotonic myopathy and chondrodysplasia","volume":"70","author":"Arikawa-Hirasawa","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nmd.2015.05.002_bib0025","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/humu.20388","article-title":"Spectrum of HSPG2 (perlecan) mutations in patients with Schwartz-Jampel syndrome","volume":"27","author":"Stum","year":"2006","journal-title":"Hum Mutat"},{"key":"10.1016\/j.nmd.2015.05.002_bib0030","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/86941","article-title":"Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene","volume":"27","author":"Arikawa-Hirasawa","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.nmd.2015.05.002_bib0035","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ejmg.2010.06.005","article-title":"Phenotypic and molecular characterization of a novel case of dyssegmental dysplasia, Silverman-Handmaker type","volume":"53","author":"Rieubland","year":"2010","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.nmd.2015.05.002_bib0040","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/15537","article-title":"Perlecan is essential for cartilage and cephalic development","volume":"23","author":"Arikawa-Hirasawa","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.nmd.2015.05.002_bib0045","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1083\/jcb.147.5.1109","article-title":"Perlecan maintains the integrity of cartilage and some basement membranes","volume":"147","author":"Costell","year":"1999","journal-title":"J Cell Biol"},{"key":"10.1016\/j.nmd.2015.05.002_bib0050","doi-asserted-by":"crossref","first-page":"11174","DOI":"10.1021\/bi8013938","article-title":"Diverse cell signaling events modulated by perlecan","volume":"47","author":"Whitelock","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.nmd.2015.05.002_bib0055","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/mus.21253","article-title":"Electrophysiological studies in a mouse model of Schwartz-Jampel syndrome demonstrate muscle fiber hyperactivity of peripheral nerve origin","volume":"40","author":"Echaniz-Laguna","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2015.05.002_bib0060","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.ajpath.2012.01.035","article-title":"A mouse model of Schwartz-Jampel syndrome reveals myelinating Schwann cell dysfunction with persistent axonal depolarization in vitro and distal peripheral nerve hyperexcitability when perlecan is lacking","volume":"180","author":"Bangratz","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.nmd.2015.05.002_bib0065","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1093\/hmg\/ddn213","article-title":"Evidence of a dosage effect and a physiological endplate acetylcholinesterase deficiency in the first mouse models mimicking Schwartz-Jampel syndrome neuromyotonia","volume":"17","author":"Stum","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2015.05.002_bib0070","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1083\/jcb.145.4.911","article-title":"Acetylcholinesterase clustering at the neuromuscular junction involves perlecan and dystroglycan","volume":"145","author":"Peng","year":"1999","journal-title":"J Cell Biol"},{"key":"10.1016\/j.nmd.2015.05.002_bib0075","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1038\/mt.2012.34","article-title":"Protein-anchoring strategy for delivering acetylcholinesterase to the neuromuscular junction","volume":"20","author":"Ito","year":"2012","journal-title":"Mol Ther"},{"key":"10.1016\/j.nmd.2015.05.002_bib0080","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","article-title":"Fast and accurate long-read alignment with Burrows-Wheeler transform","volume":"26","author":"Li","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.nmd.2015.05.002_bib0085","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1101\/gr.129684.111","article-title":"VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing","volume":"22","author":"Koboldt","year":"2012","journal-title":"Genome Res"},{"key":"10.1016\/j.nmd.2015.05.002_bib0090","doi-asserted-by":"crossref","first-page":"65ra4","DOI":"10.1126\/scitranslmed.3001756","article-title":"Carrier testing for severe childhood recessive diseases by next-generation sequencing","volume":"3","author":"Bell","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.nmd.2015.05.002_bib0095","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.nmd.2013.07.005","article-title":"Peripheral nerve hyperexcitability with preterminal nerve and neuromuscular junction remodeling is a hallmark of Schwartz-Jampel syndrome","volume":"23","author":"Bauche","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2015.05.002_bib0100","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nn801","article-title":"Absence of acetylcholinesterase at the neuromuscular junctions of perlecan-null mice","volume":"5","author":"Arikawa-Hirasawa","year":"2002","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.nmd.2015.05.002_bib0105","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00439-009-0752-4","article-title":"Transposable elements in disease-associated cryptic exons","volume":"127","author":"Vorechovsky","year":"2010","journal-title":"Hum Genet"},{"key":"10.1016\/j.nmd.2015.05.002_bib0110","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/hmg\/ddl484","article-title":"Reduced perlecan in mice results in chondrodysplasia resembling Schwartz-Jampel syndrome","volume":"16","author":"Rodgers","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2015.05.002_bib0115","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1042\/bj3590153","article-title":"A role for the perlecan protein core in the activation of the keratinocyte growth factor receptor","volume":"359","author":"Ghiselli","year":"2001","journal-title":"Biochem J"},{"key":"10.1016\/j.nmd.2015.05.002_bib0120","doi-asserted-by":"crossref","first-page":"5178","DOI":"10.1074\/jbc.M509500200","article-title":"Targeting perlecan in human keratinocytes reveals novel roles for perlecan in epidermal formation","volume":"281","author":"Sher","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2015.05.002_bib0125","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.abb.2007.10.006","article-title":"The core protein of growth plate perlecan binds FGF-18 and alters its mitogenic effect on chondrocytes","volume":"468","author":"Smith","year":"2007","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.nmd.2015.05.002_bib0130","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1021\/cr010213m","article-title":"Heparan sulfate: a complex polymer charged with biological activity","volume":"105","author":"Whitelock","year":"2005","journal-title":"Chem Rev"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896615001534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896615001534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:03:02Z","timestamp":1760774582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896615001534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0960896615001534"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2015.05.002","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A missense mutation in domain III in HSPG2 in Schwartz\u2013Jampel syndrome compromises secretion of perlecan into the extracellular space","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2015.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}